Lithium during maintenance electroconvulsive therapy: Secondary neuropsychological outcomes from the open-label PRASED randomized controlled trial
Journal of Affective Disorders · 2027-01 · 417 · 122596
DOI: 10.1016/j.jad.2026.122596 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2027-01. Verfasst von Liese Van den Eynde und 16 weiteren Autor:innen. Beteiligte Einrichtung: KU Leuven - University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium;…. Hauptthemen laut MEDLINE: Electroconvulsive Therapy, Major Depressive Disorder, Lithium Compounds. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
BACKGROUND: Lithium is commonly used for relapse prevention after successful electroconvulsive therapy (ECT). However, the combination of lithium and ECT has warranted caution in clinical practice due to concerns about cognitive tolerability, while evidence remains inconclusive. OBJECTIVE: To evaluate the neuropsychological effects of maintenance ECT (M-ECT), with and without lithium, in patients with major depressive disorder (MDD) across all ages. METHODS: The Preventing Relapse After Successful Electroconvulsive therapy for Depression (PRASED) study was a multicenter, open-label, randomized controlled trial. Patients who achieved remission after an acute ECT course for MDD were randomized to receive symptom driven M-ECT and maintenance pharmacotherapy with or without adjunctive lithium. In this secondary outcome analysis, neuropsychological functioning was assessed repeatedly over six months using a comprehensive test battery covering global cognition, memory, attention, fluency, processing speed and subjective memory complaints. Linear mixed-effects models were applied to examine group differences in cognitive trajectories over time and associations between serum lithium levels and cognitive outcomes. RESULTS: No significant differences in cognitive trajectories were observed between the lithium (n = 50) and non‑lithium (n = 46) group. Neuropsychological performance improved over time in both groups across all cognitive domains except verbal fluency. Serum lithium levels were not associated with neuropsychological performance. CONCLUSION: Lithium addition during M-ECT was not associated with impaired objective or subjective neuropsychological functioning. These findings support the neuropsychological tolerability of concurrent lithium and ECT use in the maintenance phase and may help guide treatment decisions regarding relapse prevention following successful ECT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KU Leuven - University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium; KU Leuven, Department of Neurosciences, Psychiatry, Leuven, Belgium.…
- KU Leuven - University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium; KU Leuven, Department of Neurosciences, Psychiatry, Leuven, Belgium.
- KU Leuven - University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium; KU Leuven, Department of Humanities and Social Sciences, Clinical Psy…
- Scientific Initiative for Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medi…
- KU Leuven, Department of Neurosciences, Psychiatry, Leuven, Belgium.
- BRAINM, Neuromodulation Clinics, Quellinstraat 38, 2018, Antwerp, Belgium.
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Van den Eynde, L., Vansteelandt, K., Obbels, J., Denayer, N., Verspecht, S., Hebbrecht, K., Gezels, L., Lambrichts, S., Belge, J. B., Dellink, A., Laroy, M., Coppens, V., Van Diermen, L., Gistelinck, L., Birkenhäger, T., Schrijvers, D., & Sienaert, P. (2027). Lithium during maintenance electroconvulsive therapy: Secondary neuropsychological outcomes from the open-label PRASED randomized controlled trial. Journal of Affective Disorders, 417, 122596. https://doi.org/10.1016/j.jad.2026.122596
Vancouver
Van den Eynde L, Vansteelandt K, Obbels J, Denayer N, Verspecht S, Hebbrecht K, et al. Lithium during maintenance electroconvulsive therapy: Secondary neuropsychological outcomes from the open-label PRASED randomized controlled trial. Journal of Affective Disorders. 2027;417:122596. doi:10.1016/j.jad.2026.122596
BibTeX
@article{VandenEynde2027,
author = {Van den Eynde, Liese and Vansteelandt, Kristof and Obbels, Jasmien and Denayer, Nathalie and Verspecht, Shauni and Hebbrecht, Kaat and Gezels, Liselotte and Lambrichts, Simon and Belge, Jean-Baptiste and Dellink, Annelies and Laroy, Maarten and Coppens, Violette and Van Diermen, Linda and Gistelinck, Lennart and Birkenhäger, Tom and Schrijvers, Didier and Sienaert, Pascal},
title = {Lithium during maintenance electroconvulsive therapy: Secondary neuropsychological outcomes from the open-label PRASED randomized controlled trial},
journal = {Journal of Affective Disorders},
year = {2027},
volume = {417},
pages = {122596},
doi = {10.1016/j.jad.2026.122596}
}
EUVIMED